Monica Huszar

TL;DR: The capacity of copper oxide‐containing wound dressings to enhance wound healing is proved and light is shed on the molecular mechanisms by which Copper oxide‐impregnated dressings stimulate wound healing.

TL;DR: L1CAM has been shown to be the best-ever published prognostic factor in FIGO stage I, type I endometrial cancers and shows clear superiority over the standardly used multifactor risk score.

TL;DR: It is shown that IL-1β inhibition stably reduces tumor growth by limiting inflammation and inducing the maturation of immature myeloid cells into M1 macrophages, and is suggested as an effective antitumor therapy.

TL;DR: The abilities of the assay to identify 42 tumor types with high accuracy and to maintain the same performance in samples from patients clinically diagnosed with CUP promise improved utility in the diagnosis of cancers of unknown/uncertain primary origins.

TL;DR: The results suggest that L1 expression in tumors is not ubiquitous but restricted to certain subtypes and may be a helpful molecular marker for differential diagnosis and target for antibody-based therapy.